Dimethylformamide → HCID 178501266、化合物
反応式
[CH3:1][O:2][C:3]([C@@H:5]1[CH2:10][CH2:9][C@H:8]([O:11][C:12]2[CH:20]=[CH:19][C:15]([C:16]([OH:18])=O)=[CH:14][CH:13]=2)[CH2:7][CH2:6]1)=[O:4].C(N(C(C)C)CC)(C)C.[Cl:30][C:31]1[CH:32]=[C:33]([C:37]2[S:41][C:40]([NH2:42])=[N:39][N:38]=2)[CH:34]=[CH:35][CH:36]=1.CN(C=O)C>ClCCl.O>[Cl:30][C:31]1[CH:32]=[C:33]([C:37]2[S:41][C:40]([NH:42][C:16]([C:15]3[CH:14]=[CH:13][C:12]([O:11][C@@H:8]4[CH2:7][CH2:6][C@H:5]([C:3]([O:2][CH3:1])=[O:4])[CH2:10][CH2:9]4)=[CH:20][CH:19]=3)=[O:18])=[N:39][N:38]=2)[CH:34]=[CH:35][CH:36]=1参加物
実験手順
0.351 g of cis-4-(4-methoxycarbonylcyclohexyloxy)benzoic acid (1.26 mmol, 1 eq.) is placed in 5 mL of dichloromethane at room temperature. 0.42 mL of diisopropylethylamine (2.52 mmol, 2 eq.), 0.705 g of bromotris-pyrrolidinophosphonium hexafluorophosphonate (1.51 mmol, 1.2 eq.) and 0.267 g of 3-chlorophenyl-1,3,4-thiadiazol-2-amine (1.26 mmol, 1 eq.) are added successively. 2 mL of DMF are added. The reaction mixture is stirred for 1 day at room temperature, diluted in dichloromethane, and water is added. Filtration of this medium gives 0.06 g of methyl cis-4-{4-[5-(3-chlorophenyl)[1.3.4]thiadiazol-2-ylcarbamoyl]phenoxy}cyclohexanecarboxylate. The organic phase is separated out by settling, washed with water, dried over sodium sulfate, filtered and evaporated. The residue is taken up in ethanol, filtered off by suction and washed with diethyl ether. 0.090 g of methyl cis-4-{4-[5-(3-chlorophenyl)[1.3.4]thiadiazol-2-ylcarbamoyl]phenoxy}cyclohexanecarboxylate is obtained.
後処理
- filtrationFiltration of this medium
出典と根拠
- ORDレコード
- ord-b73a4786297b475b8eed74b75d126587
- 出典データセット
- uspto-grants-2013_10
- 特許番号
- US08546391B2
反応ノート
読み込み中…